demonstrated that down-regulated expression of RBM15 dramatically inhibited proliferation of PAAD cell lines and RBM15 may be a prognostic biomarker and immunotherapeutic predictor in PAAD (23). The gene discussed is RBM15; the disease is pancreatic adenocarcinoma.